Apellis Pharmaceuticals, Inc. ($APLS)
Filing Information
| Accession Number | 0001492422-26-000039 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
2,892
Total Value
$57,241.07
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 20, 2026 | Sale | 2,892 | $19.79 | $57,241.07 | 104,188 | Direct | โ | View Details |